5251 - 5275 of 9038 Results
Title
Year
-
OPENTitle: Four‐Year Follow‐up of [18F]Fluorodeoxyglucose Positron Emission Tomography–Based Parkinson's Disease–Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 230End Page: 235Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28260Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28260Citation Count: 47
-
OPENTitle: GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian CohortJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2106End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28195Best OA location URL: http://hdl.handle.net/11573/1433077Citation Count: 144
-
OPENTitle: A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the NetherlandsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1667End Page: 1674Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28112Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28112Citation Count: 71
- PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression2020RESTRICTEDTitle: PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 606End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27963Citation Count: 40
-
OPENTitle: Modernizing Daily Function Assessment in Parkinson's Disease Using Capacity, Perception, and Performance MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 76End Page: 82Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28377Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28377Citation Count: 66
- Telemedicine in Movement Disorders: Leçons du COVID‐192020RESTRICTEDTitle: Telemedicine in Movement Disorders: Leçons du COVID‐19Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1893End Page: 1896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28297Citation Count: 30
-
OPENTitle: Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrainJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 111Issue #:Start Page: 277End Page: 291Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2023.04.008Best OA location URL: https://doi.org/10.1016/j.bbi.2023.04.008Citation Count: 20
-
OPENTitle: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1247End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad139Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10895336/pdf/nihms-1962140.pdfCitation Count: 39
-
OPENTitle: The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 7Start Page: 3158End Page: 3170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12966Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12966Citation Count: 26
-
OPENTitle: Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classificationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 190Issue #:Start Page: 106373End Page: 106373Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106373Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106373Citation Count: 43
-
OPENTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9756875Citation Count: 1
-
OPENTitle: No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological SignificanceJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 653End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28935Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940713Citation Count: 8
-
OPENTitle: Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page: S32End Page: S35Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13538Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13538Citation Count: 4
-
OPENTitle: Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 111Issue #: 7Start Page: 2626End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1318306111Best OA location URL: https://www.pnas.org/content/pnas/111/7/2626.full.pdfCitation Count: 367
-
OPENTitle: Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1Journal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 34Issue #: 22Start Page: 2840End Page: 2861Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.15252/embj.201591593Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201591593Citation Count: 187
-
OPENTitle: Large-scale replication and heterogeneity in Parkinson disease genetic lociJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 7Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318264e353Best OA location URL: https://n.neurology.org/content/neurology/79/7/659.full.pdfCitation Count: 132
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions2010OPENTitle: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 42Issue #: 3Start Page: 234End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.536Best OA location URL: http://doi.org/10.1038/ng.536Citation Count: 612
-
OPENTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3160280Citation Count: 121
-
OPENTitle: Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 6Start Page: 1514.e1End Page: 1514.e12Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.01.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2014.01.010Citation Count: 50
-
OPENTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 94
-
OPENTitle: Widespread sex differences in gene expression and splicing in the adult human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 2771End Page: 2771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/ncomms3771Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/75c8359f-d7e0-4c9d-8d86-c004995b7417Citation Count: 338
-
OPENTitle: Genetic variability in the regulation of gene expression in ten regions of the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page: 1418End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3801Best OA location URL: http://doi.org/10.1038/nn.3801Citation Count: 711
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 497
-
OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 95
-
OPENTitle: Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 22Issue #: 2Start Page: 328End Page: 344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds431Best OA location URL: https://academic.oup.com/hmg/article-pdf/22/2/328/1857445/dds431.pdfCitation Count: 75